UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): March 30, 2011


POSITIVEID CORPORATION

(Exact name of registrant as specified in its charter)


 

 

 

 

 

DELAWARE

 

001-33297

 

06-1637809

  

 

  

 

 

(State or other Jurisdiction
of Incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)


1690 SOUTH CONGRESS AVENUE, SUITE 200

 

 

DELRAY BEACH, FLORIDA

 

33445

  

 

 

(Address of Principal Executive Offices)

 

(Zip Code)


Registrant’s telephone number, including area code: 561-805-8008


                                                                                                            

(Former name or former address if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

 

o

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

o

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

o

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

o

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 

Item 3.01   Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing


On March 30, 2011, PositiveID Corporation (the “Company”) (NASDAQ: PSID) received a letter from the staff of The NASDAQ Stock Market (“Nasdaq”) notifying the Company that its stockholders’ equity of $1,606,000 (reflected in the Company’s consolidated balance sheet as of December 31, 2010 included in the Company’s 2010 annual report on Form 10-K) is less than the $2,500,000 minimum required of companies listed on the Nasdaq Capital Market under the Equity Standard set forth in Listing Rule 5550(b)(1). Accordingly, a Nasdaq Hearings Panel (the “Panel”) will consider this matter, along with the Company’s previously disclosed non-compliance with Nasdaq’s $1.00 per share minimum bid price requirement, at an oral hearing currently scheduled for April 28, 2011.


At the hearing, the Company will present a plan to regain compliance to the Panel and request that the Panel grant the Company an exception to Nasdaq’s continued listing standards to implement that plan. Under Listing Rule 5815(c)(1), the Panel has the authority to grant such an exception for a period not to exceed 180 days, with the exception period commencing as of the date of the Nasdaq staff’s notification of the deficiency for which the exception is granted. There can be no assurance that the Panel will accept the Company’s compliance plan or grant the Company’s request for an exception to the continued listing standards.




2




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


PositiveID Corporation



Date: April 1, 2011


/s/ William J. Caragol                           

William J. Caragol 

President and Chief Financial Officer 



3